ALTURiX CEYESTO® Granted Expanded UK Indication By the MHRA
Announced today, ALTURiX - a rapidly-growing British pharmaceutical company - has been granted an expanded indication in the UK for CEYESTO® 3mg Tablets, an immediate release form of melatonin. CEYESTO® has been available in the UK for over a year for the short term treatment of jet lag in adults, and has now also ...
Source: pharmiweb.com